NCT00866788
- Conditions
- Chronic Disease, Chronic Idiopathic Urticaria, Chronic Urticaria, +10 more
- Locations
-
Not specified
Clinical trial condition
Hypersensitivity, Immediate
Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.
6,736 public trials
631 recruiting studies
Hypersensitivity, Immediate trial results
NCT01332357
- Conditions
- Asthma, Bronchial Diseases, Disease Attributes, +10 more
- Locations
-
Not specified
- Conditions
- Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +8 more
- Locations
-
- GSK Investigational Site Nanjing, Jiangsu, China
- GSK Investigational Site Chengdu, Sichuan, China
- GSK Investigational Site Hangzhou, Zhejiang, China
- GSK Investigational Site Beijing, China
NCT01328964
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
Not specified
NCT01691612
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Asthma Research Center Boston, Massachusetts, United States
NCT00806442
- Conditions
- Asthma, Bronchial Asthma, Bronchial Diseases, +7 more
- Locations
-
- Asthma Research Center, Brigham and Women's Hospital Boston, Massachusetts, United States
NCT00078208
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT01189396
- Conditions
- Asthma, Bronchial Diseases, Bronchial Spasm, +14 more
- Locations
-
- Amphastar Site 0025 Medford, Oregon, United States
- Amphastar Site 0026 Portland, Oregon, United States
- Amphastar Site 0032 San Antonio, Texas, United States
- Amphastar Site 0034 Seattle, Washington, United States
NCT02433834
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Pearl Therapeutics Inc. Birmingham, Alabama, United States
- Pearl Therapeutics Inc. Anaheim, California, United States
- Pearl Therapeutics Inc. Bakersfield, California, United States
- Pearl Therapeutics Inc. Cerritos, California, United States
NCT01715844
- Conditions
- Asthma, Body Weight, Bronchial Diseases, +14 more
- Locations
-
- Asthma Institute, University of Pittsburgh Pittsburgh, Pennsylvania, United States